These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 16476531)

  • 1. Synthesis and evaluation of the mucoadhesivity of a CD-chitosan derivative.
    Venter JP; Kotzé AF; Auzély-Velty R; Rinaudo M
    Int J Pharm; 2006 Apr; 313(1-2):36-42. PubMed ID: 16476531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydroxypropyl chitosan bearing beta-cyclodextrin cavities: synthesis and slow release of its inclusion complex with a model hydrophobic drug.
    Prabaharan M; Mano JF
    Macromol Biosci; 2005 Oct; 5(10):965-73. PubMed ID: 16208630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan--a review.
    George M; Abraham TE
    J Control Release; 2006 Aug; 114(1):1-14. PubMed ID: 16828914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug carrier systems based on water-soluble cationic beta-cyclodextrin polymers.
    Li J; Xiao H; Li J; Zhong Y
    Int J Pharm; 2004 Jul; 278(2):329-42. PubMed ID: 15196638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
    Badr-Eldin SM; Elkheshen SA; Ghorab MM
    Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-aggregates formation and mucoadhesive property of water-soluble β-cyclodextrin grafted with chitosan.
    Sajomsang W; Gonil P; Ruktanonchai UR; Pimpha N; Sramala I; Nuchuchua O; Saesoo S; Chaleawlert-umpon S; Puttipipatkhachorn S
    Int J Biol Macromol; 2011 May; 48(4):589-95. PubMed ID: 21300088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclodextrin-based supramolecular architectures: syntheses, structures, and applications for drug and gene delivery.
    Li J; Loh XJ
    Adv Drug Deliv Rev; 2008 Jun; 60(9):1000-17. PubMed ID: 18413280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances and potential applications of chitosan derivatives as mucoadhesive biomaterials in modern drug delivery.
    Chopra S; Mahdi S; Kaur J; Iqbal Z; Talegaonkar S; Ahmad FJ
    J Pharm Pharmacol; 2006 Aug; 58(8):1021-32. PubMed ID: 16872548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increasing the cyclodextrin complexation of drugs and drug biovailability through addition of water-soluble polymers.
    Loftsson T
    Pharmazie; 1998 Nov; 53(11):733-40. PubMed ID: 9853355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel mucoadhesion tests for polymers and polymer-coated particles to design optimal mucoadhesive drug delivery systems.
    Takeuchi H; Thongborisute J; Matsui Y; Sugihara H; Yamamoto H; Kawashima Y
    Adv Drug Deliv Rev; 2005 Nov; 57(11):1583-94. PubMed ID: 16169120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chitosan-graft-beta-cyclodextrin scaffolds with controlled drug release capability for tissue engineering applications.
    Prabaharan M; Jayakumar R
    Int J Biol Macromol; 2009 May; 44(4):320-5. PubMed ID: 19428461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chitosan-graft-β-cyclodextrin nanoparticles as a carrier for controlled drug release.
    Yuan Z; Ye Y; Gao F; Yuan H; Lan M; Lou K; Wang W
    Int J Pharm; 2013 Mar; 446(1-2):191-8. PubMed ID: 23422276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New paramagnetic supramolecular adducts for MRI applications based on non-covalent interactions between Gd(III)-complexes and beta- or gamma-cyclodextrin units anchored to chitosan.
    Aime S; Gianolio E; Uggeri F; Tagliapietra S; Barge A; Cravotto G
    J Inorg Biochem; 2006 May; 100(5-6):931-8. PubMed ID: 16412512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclodextrins and chitosan derivatives in sublingual delivery of low solubility peptides: A study using cyclosporin A, alpha-cyclodextrin and quaternary chitosan N-betainate.
    Mannila J; Järvinen K; Holappa J; Matilainen L; Auriola S; Jarho P
    Int J Pharm; 2009 Oct; 381(1):19-24. PubMed ID: 19632311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of bioadhesive polymers as delivery systems for nose to brain delivery: in vitro characterisation studies.
    Charlton ST; Davis SS; Illum L
    J Control Release; 2007 Apr; 118(2):225-34. PubMed ID: 17261340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chitosan/cyclodextrin nanoparticles as macromolecular drug delivery system.
    Krauland AH; Alonso MJ
    Int J Pharm; 2007 Aug; 340(1-2):134-42. PubMed ID: 17459620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Theoretical and experimental study of a praziquantel and beta-cyclodextrin inclusion complex using molecular mechanic calculations and H1-nuclear magnetic resonance.
    de Jesus MB; de Matos Alves Pinto L; Fraceto LF; Takahata Y; Lino AC; Jaime C; de Paula E
    J Pharm Biomed Anal; 2006 Jun; 41(4):1428-32. PubMed ID: 16678375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of cyclodextrins on the proliferation of HaCaT keratinocytes in vitro.
    Hipler UC; Schönfelder U; Hipler C; Elsner P
    J Biomed Mater Res A; 2007 Oct; 83(1):70-9. PubMed ID: 17380497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-assembled cyclodextrin aggregates and nanoparticles.
    Messner M; Kurkov SV; Jansook P; Loftsson T
    Int J Pharm; 2010 Mar; 387(1-2):199-208. PubMed ID: 19963052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and spectral investigation of Al(III) catechin/beta-cyclodextrin and Al(III) quercetin/beta-cyclodextrin inclusion compounds.
    Dias K; Nikolaou S; De Giovani WF
    Spectrochim Acta A Mol Biomol Spectrosc; 2008 Jun; 70(1):154-61. PubMed ID: 18054838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.